| DESCRIPTION | - BORUDE et al., Hepatology, (20120000), vol. 56, no. 6, pages 2336 - 43 | - |
| DESCRIPTION | - CARR, RM et al., "Current Atherosclerosis Reports", Current Science, vol. 17, no. 4, pages 1 - 14 | - |
| DESCRIPTION | - DAI G et al., Hepatology, (20080000), vol. 47, no. 4, pages 1277 - 87 | - |
| DESCRIPTION | - ETRA JW et al., HPB (Oxford, (20140000), vol. 16, no. 10, pages 875 - 83 | - |
| DESCRIPTION | - GRAAF W et al., Br J Surg, (20110000), vol. 98, no. 6, pages 825 - 34 | - |
| DESCRIPTION | - GRADY et al., Postgrad Med J, (20050000), vol. 81, page 148 | - |
| DESCRIPTION | - HOEKSTRA et al., J. Surgical Research, (20120000), vol. 178, pages 773 - 778 | - |
| DESCRIPTION | - HUANG W et al., Science, (20060000), vol. 312, no. 5771, pages 233 - 6 | - |
| DESCRIPTION | - LANDRIER et al., Am J Physiol Gastrointest Liver Physiol, (20060000), vol. 290, no. 5, pages G923 - 32 | - |
| DESCRIPTION | - LIONARONS et al., Sci Rep, (20160000), vol. 6, page 31829 | - |
| DESCRIPTION | - LOOS CM et al., JHistochem Cytochem, (20130000), vol. 61, no. 1, pages 11 - 8 | - |
| DESCRIPTION | - MARSMAN HA et al., Br J Surg, (20130000), vol. 100, no. 5, pages 674 - 83 | - |
| DESCRIPTION | - MICHALOPOULOS et al., Science, (19970000), vol. 276, pages 60 - 66 | - |
| DESCRIPTION | - MOSCHETTA et al., Gastroenterology, (20150000), vol. 149, no. 3, pages 728 - 40 | - |
| DESCRIPTION | - NAUGLER, PLoS One, (20140000), vol. 9, no. 5, page e97426 | - |
| DESCRIPTION | - OLDHAFER et al., Ann Surg, (20160000), vol. 263, no. 5, pages 839 - 41 | - |
| DESCRIPTION | - RAMAKERS C et al., Neurosci Lett, (20030000), vol. 339, no. 1, pages 62 - 6 | - |
| DESCRIPTION | - SHINDOH J et al., JAm Coll Surg, (20130000), vol. 217, no. 1, pages 126 - 33 | - |
| DESCRIPTION | - SHIRABE K et al., Scand J Surg, (20130000), vol. 102, no. 2, pages 101 - 5 | - |
| DESCRIPTION | - URIARTE et al., Gut, (20130000), vol. 62, no. 6, pages 899 - 910 | - |
| DESCRIPTION | - VAN DEN ESSCHERT et al., Ann Surg, (20120000), vol. 255, no. 2, pages 311 - 8 | - |
| DESCRIPTION | - VAN DER GAAG et al., N Engl J Med, (20100000), vol. 362, no. 2, pages 129 - 37 | - |
| DESCRIPTION | - WEST GB et al., J Exp Biol, (20050000), vol. 208, pages 1575 - 92 | - |
| DESCRIPTION | - WILLIAMS et al., Lancet, (19930000), vol. 342, page 273 | - |
| OPPOSITION | - Anonymous, "Intercept Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution and Cirrhosis Prevention in High-Risk NASH Patients OCA Treatment Resulted in Significant Improvements in Fibrosis Resolution in Addition to Previously Reported Benefits on Fibrosis Improvement, NASH Resolution and NAS Score Improvement", (20150423), pages 1 - 3, Interceptpharma, URL: https://ir.interceptpharma.com/static-files/5cd470fd-db66-44b0-a1eb-80f5beabc334, (20231030), XP093096246 | - |
| OPPOSITION | - Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN)", WHO Drug Information, (20090101), vol. 23, no. 2, pages 129 - 192, XP055858023 | - |
| OPPOSITION | - Anonymous, "Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)", Clinical trials, (20140626), pages 1 - 5, XP093098254 | - |
| OPPOSITION | - Anonymous, "Public summary of opinion on orphan designation 6alpha-ethyl-chenodeoxycholic acid for treatment of primary biliary cirrhosis ", (20100804), pages 1 - 4, European Medicines agency , URL: https://www.ema.europa.eu/en/documents/orphan-designation/eu/3/10/753-public-summary-opinion-orphan-designation-6alpha-ethyl-chenodeoxycholic-acid-treatment-primary_en.pdf, (20231012), XP093091098 | - |
| OPPOSITION | - Anonymous, "Public summary of opinion on orphan designation - Obeticholic acid for the treatment of primary sclerosing cholangitis", (20140321), pages 1 - 4, European Medicines Agency, URL: https://www.ema.europa.eu/en/documents/orphan-designation/eu/3/13/1228-public-summary-opinion-orphan-designation-obeticholic-acid-treatment-primary-sclerosing_en.pdf, (20231012), XP093091155 | - |
| OPPOSITION | - Anonymous, "Study of INT-747 as Monotherapy in Patients With PBC", Clinical trials, (20120109), pages 1 - 9, XP093098255 | - |
| OPPOSITION | - Anonymous, "The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) (FLINT)", Clinical trials, (20150727), pages 1 - 46, XP093098259 | - |
| OPPOSITION | - Cienfuegos Javier A, Rotellar Fernando, Baixauli Jorge, Martínez-Regueira Fernando, Pardo Fernando, Hernández-Lizoáin José Luis, "Liver regeneration--the best kept secret. A model of tissue injury response", Revista española de enfermedades digestivas, ES , (20140301), vol. 106, no. 3, ISSN 1130-0108, pages 171 - 194, XP093091150 | - |
| OPPOSITION | - Mason Andrew L, Lindor Keith D, Hirschfield Gideon M, Gordon Stuart C, Moyo Marlyn J, Kowd Kris V, Pares Albert, Trouner Michael, Sciacca Cathi I, Ssa Be9cher Jones Te, Pruzanski Mark, Shapiro David A, "FARNESOID·X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTER· NATIONAL STUDY EVALUATING THE ADDITION OF OBETICHOLIC ACID (INT·747) TO URSODEOXYCHOLIC ACID ", Hematology AASLD Abstracts, (20100101), no. 4, pages 257A - 257A, XP093096335 | - |
| OPPOSITION | - Zhang Lisheng, Wang Yan-Dong, Chen Wei-Dong, Wang Xichun, Lou Guiyu, Liu Nian, Lin Min, Forman Barry M., Huang Wendong, "Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice", Hepatology, US , (20121201), vol. 56, no. 6, doi:10.1002/hep.25905, ISSN 0270-9139, pages 1 - 15, XP093091116 | |
| OPPOSITION | - Vyas Soumil; Markar Sheraz; Partelli Stefano; Fotheringham Tim; Low Deborah; Imber Charles; Malago Massimo; Kocher Hemant M., "Portal Vein Embolization and Ligation for Extended Hepatectomy", Indian Journal of Surgical Oncology, India , (20140106), vol. 5, no. 1, doi:10.1007/s13193-013-0279-y, ISSN 0975-7651, pages 30 - 42, XP035305140 | |
| OPPOSITION | - Fan Mingjie, Ding Lili, Huang Wendong, "Bile Acid Receptors and Liver Regeneration", Liver Regeneration : Basic Mechanisms , relevant Models and Clinical Applications, Elsevier, (20150101), pages 125 - 135, doi:10.1016/B978-0-12-420128-6.00009-9, ISBN 978-0-12-420128-6, XP093096263 | |
| OPPOSITION | - Poynard Thierry, Francoise Imbert-Bismut, "Laboratory Testing for Liver Disease", Poynard Thierry, Francoise Imbert-Bismut, Thomas D. Boyer, Michael P. Manns and Arun J. Sanyal, Zakim and Boyer's Hepatology, Saunders Elsevier , (20120101), pages 201 - 204, doi:10.1016/C2009-0-39323-X, ISBN 978-1-4377-0881-3, XP093098155 | |
| OPPOSITION | - Li Guodong, L. Guo Grace, "Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration", Acta Pharmaceutica Sinica B, (20150301), vol. 5, no. 2, doi:10.1016/j.apsb.2015.01.005, ISSN 2211-3835, pages 93 - 98, XP093091142 | |
| OPPOSITION | - Chen Wei-Dong, Wang Yan-Dong, Meng Zhipeng, Zhang Lisheng, Huang Wendong, "Nuclear bile acid receptor FXR in the hepatic regeneration", Biochimica et Biophysica Acta, NL , (20110801), vol. 1812, no. 8, doi:10.1016/j.bbadis.2010.12.006, ISSN 0925-4439, pages 888 - 892, XP093096274 | |
| OPPOSITION | - Fan Mingjie, Wang Xichun, Xu Ganyu, Yan Qingfeng, Huang Wendong, "Bile acid signaling and liver regeneration", Biochimica et Biophysica Acta, AMSTERDAM, NL , (20150201), vol. 1849, no. 2, doi:10.1016/j.bbagrm.2014.05.021, ISSN 1874-9399, pages 196 - 200, XP093091091 | |
| OPPOSITION | - Gadaleta Raffaella M., Van Mil Saskia W.C., Oldenburg Bas, Siersema Peter D., Klomp Leo W.J., Van Erpecum Karel J., "Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease", Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, AMSTERDAM, NL , (20100701), vol. 1801, no. 7, doi:10.1016/j.bbalip.2010.04.006, ISSN 1388-1981, pages 683 - 692, XP093091043 | |
| OPPOSITION | - Jing Fu, Pei Si, Mingyue Zheng, Lili Chen, Xu Shen, Yun Tang, Weihua Li, "Discovery of new non-steroidal FXR ligands via a virtual screening workflow based on Phase shape and induced fit docking", Bioorganic & Medicinal Chemistry Letters, Amsterdam NL , (20121101), vol. 22, no. 22, doi:10.1016/j.bmcl.2012.09.045, ISSN 0960-894X, pages 6848 - 6853, XP055368988 | |
| OPPOSITION | - Zhipeng Meng; Nian Liu; Xianghui Fu; Xiaoqiong Wang; Yan-dong Wang; Wei-dong Chen; Lisheng Zhang; Barry M. Forman; Wendong Huang;, "Insufficient bile acid signaling impairs liver repair inmice", Journal of Hepatology, AMSTERDAM, NL , (20101218), vol. 55, no. 4, doi:10.1016/j.jhep.2010.12.037, ISSN 0168-8278, pages 885 - 895, XP028294646 | |
| OPPOSITION | - Neuschwander-Tetri Brent A; Loomba Rohit; Sanyal Arun J; Lavine Joel E; Van Natta Mark L; Abdelmalek Manal F; Chalasani Naga; Dasarathy Srinivasan; Diehl Anna Mae; Hameed Bilal; Kowdley Kris V; McCullough Arthur; Terrault Norah; Clark Jeanne M; Tonascia James; Brunt Elizabeth M; Kleiner David E; Doo Edward; Nash Clin Res Network, "Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial", The Lancet, AMSTERDAM, NL , (20150314), vol. 385, no. 9972, doi:10.1016/S0140-6736(14)61933-4, ISSN 0140-6736, pages 956 - 965, XP009510956 | |
| OPPOSITION | - Roberto Pellicciari, Stefano Fiorucci, Emidio Camaioni, Carlo Clerici, Gabriele Costantino, Patrick R. Maloney, Antonio Morelli, Derek J. Parks, and Timothy M. Willson, "6.alpha.-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity", Journal of Medicinal Chemistry, US , (20020720), vol. 45, no. 17, doi:10.1021/jm025529g, ISSN 0022-2623, pages 3569 - 3572, XP002370635 | |
| OPPOSITION | - Roberto Pellicciari, Gabriele Costantino, Emidio Camaioni, Bahman M. Sadeghpour, Antonio Entrena, Timothy M. Willson, Stefano Fiorucci, Carlo Clerici, Antimo Gioiello, "Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid", Journal of Medicinal Chemistry, US , (20040101), vol. 47, no. 18, doi:10.1021/JM049904B, ISSN 0022-2623, pages 4559 - 4569, XP002669041 | |
| OPPOSITION | - Huang Xiong-Fei, Zhao Wei-Yu, Huang Wen-Dong, "FXR and liver carcinogenesis", Acta Pharmacologica Sinica, GB , (20150101), vol. 36, no. 1, doi:10.1038/aps.2014.117, ISSN 1671-4083, pages 37 - 43, XP093098157 | |
| OPPOSITION | - Yan-Dong Wang, Wei-Dong Chen, David D Moore, Wendong Huang, "FXR: a metabolic regulator and cell protector", Cell Research, (20081101), vol. 18, no. 11, doi:10.1038/cr.2008.289, ISSN 10010602, pages 1087 - 1095, XP055086473 | |
| OPPOSITION | - Linder Keith D, "Farnesoid X receptor agonists for primary biliary cirrhosis", Current Opinion in Gastroenterology, (20110501), vol. 27, no. 3, doi:10.1097/MOG.Ob013e32834452c8, pages 285 - 288, XP093091126 | |
| OPPOSITION | - W. Huang, "Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration", Science, US , (20060414), vol. 312, no. 5771, doi:10.1126/science.1121435, ISSN 0036-8075, pages 233 - 236, XP055160374 | |
| OPPOSITION | - Philippe Lefebvre, Bertrand Cariou, Fleur Lien, Folkert Kuipers, Bart Staels, "Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation", Physiological Reviews, US , (20090101), vol. 89, no. 1, doi:10.1152/physrev.00010.2008, ISSN 0031-9333, pages 147 - 191, XP055489509 | |
| OPPOSITION | - Tang Xiaowen, Lili Ding, Qiaoling Yang, Xiaoyuan Niu, Li Yang, Zhengtao Wang, "Advances in Bile Acids-Mediated Liver Injury and Liver Regeneration", Advances in Biochemistry, (20141201), vol. 2, no. 6, doi:10.11648/j.ab.20140206.11, ISSN 2329-0870, pages 85 - 59, XP093096271 | |
| OPPOSITION | - Meng Zhipeng, Wang Yandong, Wang Lin, Jin Wen, Liu Nian, Pan Hao, Liu Lucy, Wagman Lawrence, Forman Barry M., Huang Wendong, "FXR Regulates Liver Repair after CCl4-Induced Toxic Injury", Molecular Endocrinology, US , (20100501), vol. 24, no. 5, doi:10.1210/me.2009-0286, ISSN 0888-8809, pages 886 - 897, XP093091105 | |
| OPPOSITION | - Yimam Kidist K, Bowlus Christopher L, "Obeticholic acid for the treatment of primary biliary cirrhosis", Expert Opinion on Orphan Drugs, (20141201), vol. 2, no. 12, doi:10.1517/21678707.2014.964206, pages 1351 - 1358, XP093091136 | |
| OPPOSITION | - Kohkichi Morimoto , Hiroshi Itoh , Mitsuhiro Watanabe, "Developments in understanding bile acid metabolism", Expert Review of Endocrinology & Metabolism, (20130101), vol. 8, no. 1, doi:10.1586/eem.12.75, pages 59 - 69, XP009549243 | |
| OPPOSITION | - Ahmad H Ali, Elizabeth J Carey, Keith D Lindor, "Recent advances in the development of farnesoid X receptor agonists", Annals of translational medicine, (20150101), vol. 1, no. 5, doi:10.3978/j.issn.2305-5839.2014.12.06, pages 1 - 16, XP055522463 | |
| OPPOSITION | - Christophe Corpechot, "Primary biliary cirrhosis and bile acids", Clinics and Research in Hepatology and Gastroenterology, (20170901), vol. 36, doi:10.1016/S2210-7401(12)70016-5, pages S13 - S20, XP055723590 | |
| SEARCH | - CARR ROTONYA M ET AL, "FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease", CURRENT ATHEROSCLEROSIS REPORTS, CURRENT SCIENCE, US, vol. 17, no. 4, doi:10.1007/S11883-015-0500-2, ISSN 1523-3804, (20150218), pages 1 - 14, (20150218), XP035470130 [Y] 1-15 * page 16, column l * | |
| SEARCH | - Ahmad H Ali ET AL, "Recent advances in the development of farnesoid X receptor agonists", Annals of translational medicine, China, doi:10.3978/j.issn.2305-5839.2014.12.06, (20150101), pages 5 - 583906, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293481/pdf/atm-03-01-5.pdf, XP055522463 [Y] 1-15 * abstract * | |
